Zeria
Pre-Approval PRO BETAInactive Company
No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 8/3/2021
Pipeline by Phase
Therapeutic Focus
Clinical Trials (17)
A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia
Started: 2/22/2021
A Comparative Study of ZG-801 and Placebo in Patients With Hyperkalemia
Started: 8/3/2021
Trial to Optimally Show the Pharmacological Action of Z-100
Started: 4/2/2018
Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer
Started: 12/1/2014
Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia
Started: 7/1/2016
Efficacy Study of Intravenous Iron Preparation to Iron Deficiency Anemia
Started: 5/1/2016
Phase III, Long-term, Open-label Safety Study of Z-338
Started: 3/1/2014
Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
Started: 9/1/2010
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
Started: 9/1/2008
Exploratory Study of ZG-801 for the Treatment of Hyperkalemia
Started: 2/18/2019
To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis
Started: 5/1/2015
Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma
Started: 4/1/2014
To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects
Started: 7/1/2015
Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia
Started: 6/1/2014
Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)
Started: 7/1/2008